Last month, the Santa Clara, Calif.-based cybersecurity provider delivered an expectations-beating Q4 fiscal year financial ...

Palisade Bio is fortifying its brand image. The California-based biotech on Monday unveiled a new logo and website design, ...

We recently compiled a list of the 10 Best ESG Stocks To Buy Now. In this article, we are going to take a look at where Eli ...

Researchers discovered that IBD significantly increases the risk of developing T1D, and this association works both ways, ...

Share on Pinterest Common antibiotics may heighten the risk of inflammatory bowel disease (IBD) by damaging the gut, a mouse study suggests. Image credit: Joe Raedle/Getty Images. As of 2019 ...

As of 2019, about 4.9 million people globally were living with inflammatory bowel disease (IBD). There is currently no cure for IBD and scientists are still not sure what the exact cause of the ...

C4X Discovery Holdings LimitedPatientSeek identifies a genetic signature that separates a4b7 integrin therapy responder and non-responder ...

Certain extraintestinal manifestations (EIMs) in inflammatory bowel disease (IBD) have distinct clinical, serologic, and genetic associations that reveal underlying mechanisms and indicate targets ...

The study demonstrates that antibiotics interfere with the protective mucus layer in the intestine, a discovery that could reshape our understanding of antibiotic effects and IBD development.

The U.S. Food and Drug Administration has allowed the expanded use of Johnson & Johnson's drug, Tremfya, to treat adults with ...